SCHEMBL6608014

SCHEMBL6608014

CN(c1cc(NC(=O)O)c([N+](=O)[O-])cc1C(F)(F)F)C1CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.39
ALDH1A1 P00352 6/20 0.39
NPSR1 Q6W5P4 2/20 0.39
AR P10275 3/20 0.38
CYP3A4 P08684 2/20 0.38
MAPK1 P28482 2/20 0.38
LMNA P02545 2/20 0.38
HTT P42858 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
CES2 O00748 1/20 0.38
ABCB11 O95342 1/20 0.38
CYP1A2 P05177 1/20 0.38
GLA P06280 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
CHRM1 P11229 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
TBXA2R P21731 1/20 0.38
AADAC P22760 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6608184 0.87 MAPT (0.42) MAPTALDH1A1NPSR1ARCYP3A4
SCHEMBL5557081 0.86 LMNA (0.38) MAPTALDH1A1NPSR1ARCYP3A4
SCHEMBL6641220 0.83 MAPT (0.40) MAPTALDH1A1NPSR1LMNAHTT
SCHEMBL27615951 0.82 ALDH1A1 (0.44) MAPTALDH1A1NPSR1ARCYP3A4
SCHEMBL6607347 0.81 CFTR (0.34) AR
SCHEMBL27615830 0.80 ALDH1A1 (0.41) MAPTALDH1A1ARCYP3A4MAPK1
SCHEMBL17336846 0.79 MAPT (0.46) MAPTALDH1A1ARCYP3A4MAPK1
SCHEMBL5564851 0.78 HCAR3 (0.41) MAPTALDH1A1ARCYP3A4MAPK1
SCHEMBL22636966 0.76 AR (0.42) MAPTALDH1A1NPSR1ARCYP3A4
SCHEMBL27615854 0.76 MAPT (0.46) MAPTALDH1A1ARCYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497333-C Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2009-06-10 CN disclosed
CN-1633430-A Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2005-06-29 CN disclosed
EP-1379511-A1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II F. HOFFMANN-LA ROCHE AG (CH) 2004-01-14 EP disclosed
WO-2002083652-A1 DIHYDRO-BENZO [b] [1, 4] DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II F. HOFFMANN-LA ROCHE AG (CH) 2002-10-24 WO disclosed